A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial to Evaluate the Duration of Action of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis (MS)

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial to Evaluate the Duration of Action of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis (MS)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 29 May 2017

At a glance

  • Drugs Baclofen (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Sponsors Sun Pharma Advanced Research Company
  • Most Recent Events

    • 23 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
    • 23 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 08 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Jun 2017, as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top